Completed
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
NCT02507544
- Conditions
- Advanced Cancer, Carcinoma, Neoplasms, +2 more
- Locations
-
- START Midwest Grand Rapids, Michigan, United States
- South Texas Accelerated Research Therapeutics, LLC (START) San Antonio, Texas, United States